- Home
- TCBS vs MIRA Comparison
TCBS vs MIRA Comparison
Compare TCBS & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TCBS | MIRA |
|---|---|---|
| Founded | 1934 | 2020 |
| Country | United States | United States |
| Employees | 71 | N/A |
| Industry | Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.6M | 43.7M |
| IPO Year | 2021 | 2023 |
Fundamental Metrics
Financial Performance| Metric | TCBS | MIRA |
|---|---|---|
| Price | $16.83 | $0.98 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.5K | ★ 131.9K |
| Earning Date | 04-24-2026 | 05-13-2026 |
| Dividend Yield | ★ 1.18% | N/A |
| EPS Growth | ★ 327.27 | N/A |
| EPS | ★ 0.31 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $16.80 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.10 | $0.90 |
| 52 Week High | $20.00 | $2.45 |
Technical Indicators
Market Signals| Indicator | TCBS | MIRA |
|---|---|---|
| Relative Strength Index (RSI) | 47.27 | 40.99 |
| Support Level | $16.79 | $0.90 |
| Resistance Level | $17.13 | $1.24 |
| Average True Range (ATR) | 0.16 | 0.05 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 65.63 | 3.77 |
Price Performance
Historical ComparisonAbout TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans, commercial real estate loans, and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer, and other.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.